Kelkheim, Germany

Ottmar Jaenicke

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ottmar Jaenicke. Retrieved from https://idiyas.com/inventor/ottmar-jaenicke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ottmar Jaenicke

Introduction

Ottmar Jaenicke is a notable inventor based in Kelkheim, Germany. He is recognized for his contributions to the field of pharmaceuticals, particularly in the preparation of cefodizime. His innovative work has led to the development of processes that enhance the efficiency of drug production.

Latest Patents

Jaenicke holds a patent for a process for the preparation of cefodizime. This patent outlines a method involving the reaction of specific compounds to produce cefodizime, which is crucial in the pharmaceutical industry. His patent is a significant contribution to the field, showcasing his expertise and innovative thinking.

Career Highlights

Throughout his career, Ottmar Jaenicke has worked with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical sector. His role at Hoechst has allowed him to focus on research and development, contributing to advancements in drug formulation and production.

Collaborations

Jaenicke has collaborated with notable colleagues such as Hans Wagner and Manfred Worm. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical field.

Conclusion

Ottmar Jaenicke's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for the preparation of cefodizime highlights his significant contributions to drug development. Through his career and collaborations, he continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…